Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘Alimentary Pharmacology & Therapeutics’

February 5th, 2016

Are Fecal Transplants Effective in Children with IBD?

By Kanaaz Pereira kanaazpe

Clostridium difficile infection (CDI) is the leading cause of nosocomial diarrhea and is increasing in prevalence both in adult and paediatric populations. Moreover, those with inflammatory bowel disease (IBD) are at increased risk of CDI. Fecal microbiota transplantation (FMT) is an effective treatment for recurrent CDI, but little data is available regarding the effectiveness and associated microbiome […]

View full entry

Tags: Alimentary Pharmacology & Therapeutics, Clostridium difficile infection (CDI), fecal microbiome, fecal transplant, IBD, Mark Bartlett


August 22nd, 2014

Serrated Epithelial Changes

By Margaret Shepard, Communications Specialist Margaret_Marie

John Kisiel, M.D., discusses a recently published article in Alimentary Pharmacology & Therapeutics about serrated epithelial changes in patients with Crohn’s disease and ulcerative colitis.   Patients with inflammatory bowel disease are at an increased risk for colorectal cancer. The risk is increased by how long patients have had the disease, how old they are, […]

View full entry

Tags: Alimentary Pharmacology & Therapeutics, Crohn's disease, John Kisiel, serrated epithelial change, ulcerative colitis


June 27th, 2014

Exclusive Enteral Nutrition and Pediatric Crohn’s Disease

By Margaret Shepard, Communications Specialist Margaret_Marie

Jeanne Tung, M.D., a pediatric gastroenterologist at Mayo Clinic, discusses a recently published article in Alimentary Pharmacology & Therapeutics about exclusive enteral nutrition (EEN) in pediatric Crohn’s disease. The results show EEN was associated with remission for pediatric Crohn’s disease.   What is EEN? For several weeks to months, a patient drinks formula such as […]

View full entry

Tags: Alimentary Pharmacology & Therapeutics, Crohn's disease, EEN, exclusive enteral nutrition, Jeanne Tung, pediatric Crohn's disease


January 6th, 2014

Pregnancy and Inflammatory Bowel Disease

By Brent Westra brentwestra

When Sunanda Kane, M.D., sees female patients with inflammatory bowel disease (IBD), she is frequently asked how these conditions may affect pregnancy or the ability to get pregnant. A recent study also investigated this issue and found that there was no decrease in fertility in women with IBD who have not undergone significant abdominal or pelvic […]

View full entry

Tags: Alimentary Pharmacology & Therapeutics, fertility, pregnancy, Sunanda Kane


November 10th, 2013

Crohn’s Disease Activity Index (CDAI) & Patients with Irritable Bowel Syndrome (IBS)

By Brent Westra brentwestra

Note: This post was originally published on Mayo Clinic’s Advancing the Science blog on April 30, 2013 Edward Loftus Jr., M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses the implications of recent article published in Alimentary Pharmacology & Therapeutics that found a group of patients with […]

View full entry

Tags: Alimentary Pharmacology & Therapeutics, CDAI, Edward Loftus, IBS


Contact Us · Privacy Policy